Valley National Advisers’s Celularity CELU Stock Holding History

Valley National Advisers’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60	Buy	+100	New	+$96	﹤0.01%	1037
2023 Q3	–	Sell	-100	Closed	-$1K	–	1074
2023 Q2	$1K	Hold	100	–	–	﹤0.01%	858
2023 Q1	$1K	Hold	100	–	–	﹤0.01%	798
2022 Q4	$1K	Hold	100	–	–	﹤0.01%	774
2022 Q3	$2K	Hold	100	–	–	﹤0.01%	774
2022 Q2	$4K	Hold	100	–	–	﹤0.01%	684
2022 Q1	$9K	Hold	100	–	–	﹤0.01%	611
2021 Q4	$5K	Hold	100	–	–	﹤0.01%	682
2021 Q3	$7K	Buy	+100	New	+$8.07K	﹤0.01%	618

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Valley National Advisers's CELU Position: Q2 2026 in Review

Valley National Advisers opened a new position in Celularity (CELU) in Q2 2026: 100 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #1037 among its holdings. This is a return to the name: Valley National Advisers previously reported a position in CELU as recently as Q2 2023.

Valley National Advisers first reported a position in CELU in Q3 2021 and has held it in 9 quarters since. The position peaked at $9K in Q1 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Valley National Advisers held 100 shares of Celularity worth $60 as of Q2 2026.
Celularity was a new Valley National Advisers position in Q2 2026.
Celularity made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #1037 holding.
Valley National Advisers first reported a position in Celularity in Q3 2021 and has held it in 9 quarters since.
Valley National Advisers's Celularity position peaked at $9K in Q1 2022.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.